Cargando…
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis
Background: Acute and chronic neurodegenerative diseases represent an immense socioeconomic burden that drives the need for new disease modifying drugs. Common pathogenic mechanisms in these diseases are evident, suggesting that a platform neuroprotective therapy may offer effective treatments. Here...
Autores principales: | Logan, Ann, Belli, Antonio, Di Pietro, Valentina, Tavazzi, Barbara, Lazzarino, Giacomo, Mangione, Renata, Lazzarino, Giuseppe, Morano, Inés, Qureshi, Omar, Bruce, Lars, Barnes, Nicholas M., Nagy, Zsuzsanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468270/ https://www.ncbi.nlm.nih.gov/pubmed/36110516 http://dx.doi.org/10.3389/fphar.2022.983853 |
Ejemplares similares
-
ILB(®), a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain Injury
por: Lazzarino, Giacomo, et al.
Publicado: (2022) -
A phase II open label clinical study of the safety, tolerability and efficacy of ILB(®) for Amyotrophic Lateral Sclerosis
por: Logan, Ann, et al.
Publicado: (2022) -
ILB(®) Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral Sclerosis
por: Lazzarino, Giacomo, et al.
Publicado: (2021) -
Low Molecular Weight Dextran Sulfate (ILB(®)) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the Rat
por: Lazzarino, Giacomo, et al.
Publicado: (2020) -
Traumatic Brain Injury Alters Cerebral Concentrations and Redox States of Coenzymes Q(9) and Q(10) in the Rat
por: Lazzarino, Giacomo, et al.
Publicado: (2023)